Literature DB >> 19404263

Lubiprostone: trials and tribulations.

Michael D Crowell.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19404263     DOI： 10.1038/nrgastro.2009.62

Source DB:  PubMed          Journal:  Nat Rev Gastroenterol Hepatol        ISSN： 1759-5045            Impact factor:   46.802


× No keyword cloud information.
  6 in total

Review 1.  Restoration of barrier function in injured intestinal mucosa.

Authors:  Anthony T Blikslager; Adam J Moeser; Jody L Gookin; Samuel L Jones; Jack Odle
Journal:  Physiol Rev       Date:  2007-04       Impact factor: 37.312

2.  Recovery of mucosal barrier function in ischemic porcine ileum and colon is stimulated by a novel agonist of the ClC-2 chloride channel, lubiprostone.

Authors:  Adam J Moeser; Prashant K Nighot; Kory J Engelke; Ryuji Ueno; Anthony T Blikslager
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2006-10-19       Impact factor: 4.052

3.  Effect of a selective chloride channel activator, lubiprostone, on gastrointestinal transit, gastric sensory, and motor functions in healthy volunteers.

Authors:  Michael Camilleri; Adil E Bharucha; Ryuji Ueno; Duane Burton; George M Thomforde; Kari Baxter; Sanna McKinzie; Alan R Zinsmeister
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2006-05       Impact factor: 4.052

4.  Increased rectal mucosal enteroendocrine cells, T lymphocytes, and increased gut permeability following acute Campylobacter enteritis and in post-dysenteric irritable bowel syndrome.

Authors:  R C Spiller; D Jenkins; J P Thornley; J M Hebden; T Wright; M Skinner; K R Neal
Journal:  Gut       Date:  2000-12       Impact factor: 23.059

5.  SPI-0211 activates T84 cell chloride transport and recombinant human ClC-2 chloride currents.

Authors:  John Cuppoletti; Danuta H Malinowska; Kirti P Tewari; Qiu-Ju Li; Ann M Sherry; Myra L Patchen; Ryuji Ueno
Journal:  Am J Physiol Cell Physiol       Date:  2004-06-22       Impact factor: 4.249

6.  Clinical trial: lubiprostone in patients with constipation-associated irritable bowel syndrome--results of two randomized, placebo-controlled studies.

Authors:  D A Drossman; W D Chey; J F Johanson; R Fass; C Scott; R Panas; R Ueno
Journal:  Aliment Pharmacol Ther       Date:  2008-11-04       Impact factor: 8.171
  6 in total
  4 in total

Review 1.  [New drugs for the treatment of constipation].

Authors:  Birgit Adam; Tobias Liebregts; Guido Gerken
Journal:  Med Klin (Munich)       Date:  2010-07-30

Review 2.  New treatments for IBS.

Authors:  Magnus Halland; Nicholas J Talley
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2012-11-13       Impact factor: 46.802

Review 3.  Recent advances in small bowel diseases: Part II.

Authors:  Alan B R Thomson; Angeli Chopra; Michael Tom Clandinin; Hugh Freeman
Journal:  World J Gastroenterol       Date:  2012-07-14       Impact factor: 5.742

4.  In-vivo functional study on the involvement of CFTR, SLC26A6, NHE-1 and CA isoenzymes II and XII in uterine fluid pH, volume and electrolyte regulation in rats under different sex-steroid influence.

Authors:  Khadijeh Gholami; Sekaran Muniandy; Naguib Salleh
Journal:  Int J Med Sci       Date:  2013-07-05       Impact factor: 3.738
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.